INO · Inovio Pharmaceuticals, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“We do not currently have sufficient working capital to fund our planned operations for the next twelve months and substantial doubt exists as to our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
One customer — 100% of revenue (the years ended December 31, 2025 and 2024)
“During the years ended December 31, 2025 and 2024, we derived 100% of our revenue from ApolloBio.”
Positioning
Aug 21, 2026 · 5 days to expiryChain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 475 | 131 | — | — | $0.37 | $0.03 | — | — | 10 | 23 | |
| 594 | 478 | — | — | $0.13 | $0.08 | -0.336 | 491.4% | 31 | 33 | |
| 2.4k | 2 | 481.8% | 0.385 | $0.03 | $0.45 | -0.741 | 332.2% | 11 | 1 | |
| 1.6k | 5 | 989.7% | 0.523 | $0.01 | $1.10 | -0.794 | 482.4% | 14 | 8 | |
| 2.1k | 17 | 705.8% | 0.207 | $0.05 | $2.35 | -0.83 | 650.9% | 2 | 1 | |
| 43 | 33 | — | — | $0.17 | $3.34 | -0.455 | 1493.1% | 1 | 3 | |
| 502 | 113 | — | — | $0.17 | $3.95 | -0.854 | 851% | 2 | 12 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Jul 24, 2026–Aug 14, 2026. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.